{
  "model": "gemini-3-flash-preview",
  "taskId": "tumor-vaccine-ici",
  "runIndex": 1,
  "result": {
    "text": "- [x] `output/study_overview.json`\n- [x] `output/quantitative_findings.json`\n- [x] `output/claim_audit.json`\n- [x] `output/public_summary.json`",
    "thoughts": "**Checking the Files**\n\nI've just finished the final review of the files. All essential elements in the `output/study_overview.json` file, like titles, DOIs, publication years, domains, and study types are present and seem to be in order. The core questions are also there. I'm satisfied.\n\n\n**Validating All Data**\n\nI'm now satisfied with the file structures. I've re-examined the contents to ensure data integrity. Specifically, I confirmed that the expected fields are present within `study_overview.json`, `quantitative_findings.json`, `claim_audit.json`, and `public_summary.json`. Further, I spot-checked the `plain_language_summary` in `public_summary.json`, and it's within the required length constraints. I'm now proceeding to a final validation round to verify data accuracy across all fields. I'm also ensuring the \"domain\" field is correctly populated.\n\n\n**Concluding the Review**\n\nI've completed my final data checks. All files, including `study_overview.json`, `quantitative_findings.json`, `claim_audit.json`, and `public_summary.json`, have been meticulously reviewed. I've confirmed data types, lengths, and formatting. The evidence line references in `quantitative_findings.json` are correct. I'm now certain the output meets all the requirements.\n\n\n**Confirming Final Checks**\n\nI've just run a final, thorough review. I validated all file content, including all JSON elements, confirming the presence, format, and accuracy of each data point across all the files. I've double-checked the evidence line references, and all quotes, and can confirm that all the output files meet all of the requirements. The process is now complete.",
    "steps": [
      {
        "step": 1,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Beginning the Process**\n\nI've started by understanding my role: a filesystem extraction and summarization agent. My immediate next step is to read the `TASK.md` file. I anticipate gaining crucial instructions there to guide my subsequent actions.\n\n\n**Parsing the Instructions**\n\nI've successfully read `TASK.md`. Now, the scope of my operation is clear. My next task is to locate and access the referenced reports and schemas. I will then begin the process of data extraction and formatting, as dictated by the directives.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "TASK.md"
            },
            "output": "L1: # Agent Task\nL2: \nL3: Task id: tumor-vaccine-ici\nL4: Task title: mRNA tumor sensitization for checkpoint blockade\nL5: Reference paper: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade\nL6: Reference URL: https://www.nature.com/articles/s41586-025-09006-8\nL7: \nL8: ## Objective\nL9: Read the report and produce all required JSON outputs that satisfy their schemas.\nL10: \nL11: ## Inputs On Disk\nL12: - Report: `input/report.md`\nL13: - Schemas: in `schemas/`\nL14: \nL15: ## Required Outputs\nL16: - `output/study_overview.json` (schema: `schemas/study_overview.schema.json`)\nL17: - `output/quantitative_findings.json` (schema: `schemas/quantitative_findings.schema.json`)\nL18: - `output/claim_audit.json` (schema: `schemas/claim_audit.schema.json`)\nL19: - `output/public_summary.json` (schema: `schemas/public_summary.schema.json`)\nL20: \nL21: ## Constraints\nL22: - Do not invent source facts; derive calculations only from values in the report.\nL23: - Use line refs as `L<number>` where required.\nL24: - Where quotes are required, copy exact report snippets.\nL25: - For calculation outputs, line_refs must include every report line used for equations, constants, and numeric substitutions.\nL26: - Use relative paths only.\nL27: - Never use absolute paths.\nL28: - Never use `..` in paths.\nL29: - Write valid JSON only.\nL30: \nL31: ## Completion\nL32: Respond with a checklist of written output files.\nL33: After the checklist, stop. Do not call more tools."
          }
        ],
        "usage": {
          "promptTokens": 240,
          "responseTokens": 13,
          "thinkingTokens": 123,
          "totalTokens": 376
        },
        "costUsd": 0
      },
      {
        "step": 2,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Processing Task Details**\n\nI've got the task details now, including the task ID, reference paper, and report location. Also, I've identified the relevant schemas I will be working with. I am now preparing to process this information.\n\n\n**Reviewing Schema Structures**\n\nI'm currently reviewing the schemas to understand the required data structures. I've got the schemas loaded up and am starting to grasp the expected format for each output JSON file, particularly focusing on the fields and their relationships within the `study_overview`, `quantitative_findings`, `claim_audit`, and `public_summary` schemas.",
        "toolCalls": [
          {
            "toolName": "list_directory",
            "input": {
              "dir_path": "schemas"
            },
            "output": "claim_audit.schema.json\npublic_summary.schema.json\nquantitative_findings.schema.json\nstudy_overview.schema.json"
          }
        ],
        "usage": {
          "promptTokens": 736,
          "responseTokens": 11,
          "thinkingTokens": 159,
          "totalTokens": 906
        },
        "costUsd": 0
      },
      {
        "step": 3,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Reading the Schemas**\n\nI've begun reading the schemas, seeking an initial grasp of the data structures. My focus is on understanding the core relationships. I'll need to identify key entities and potential conflicts as I continue this deep dive.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "schemas/study_overview.schema.json"
            },
            "output": "L1: {\nL2:   \"$schema\": \"http://json-schema.org/draft-07/schema#\",\nL3:   \"title\": \"schemas-study_overview\",\nL4:   \"type\": \"object\",\nL5:   \"properties\": {\nL6:     \"paper\": {\nL7:       \"type\": \"object\",\nL8:       \"properties\": {\nL9:         \"title\": {\nL10:           \"type\": \"string\",\nL11:           \"minLength\": 10\nL12:         },\nL13:         \"doi\": {\nL14:           \"type\": \"string\",\nL15:           \"pattern\": \"^10\\\\.\"\nL16:         },\nL17:         \"publication_year\": {\nL18:           \"type\": \"integer\",\nL19:           \"minimum\": 1900,\nL20:           \"maximum\": 2100\nL21:         },\nL22:         \"domain\": {\nL23:           \"type\": \"string\",\nL24:           \"enum\": [\nL25:             \"oncology-immunology\",\nL26:             \"exoplanet-atmospheres\",\nL27:             \"climate-science\",\nL28:             \"neuroscience\",\nL29:             \"other\"\nL30:           ]\nL31:         },\nL32:         \"study_type\": {\nL33:           \"type\": \"string\",\nL34:           \"enum\": [\nL35:             \"preclinical+retrospective\",\nL36:             \"observational-astronomy\",\nL37:             \"randomized-trial\",\nL38:             \"simulation\",\nL39:             \"mixed\"\nL40:           ]\nL41:         }\nL42:       },\nL43:       \"required\": [\nL44:         \"title\",\nL45:         \"doi\",\nL46:         \"publication_year\",\nL47:         \"domain\",\nL48:         \"study_type\"\nL49:       ],\nL50:       \"additionalProperties\": false\nL51:     },\nL52:     \"core_question\": {\nL53:       \"type\": \"string\",\nL54:       \"minLength\": 20\nL55:     },\nL56:     \"datasets_or_cohorts\": {\nL57:       \"type\": \"array\",\nL58:       \"items\": {\nL59:         \"type\": \"object\",\nL60:         \"properties\": {\nL61:           \"id\": {\nL62:             \"type\": \"string\",\nL63:             \"pattern\": \"^[a-z0-9-]+$\"\nL64:           },\nL65:           \"label\": {\nL66:             \"type\": \"string\",\nL67:             \"minLength\": 3\nL68:           },\nL69:           \"sample_size_or_observations\": {\nL70:             \"type\": \"string\",\nL71:             \"minLength\": 1\nL72:           },\nL73:           \"description\": {\nL74:             \"type\": \"string\",\nL75:             \"minLength\": 20\nL76:           }\nL77:         },\nL78:         \"required\": [\nL79:           \"id\",\nL80:           \"label\",\nL81:           \"sample_size_or_observations\",\nL82:           \"description\"\nL83:         ],\nL84:         \"additionalProperties\": false\nL85:       },\nL86:       \"minItems\": 2,\nL87:       \"maxItems\": 8\nL88:     },\nL89:     \"major_limitations\": {\nL90:       \"type\": \"array\",\nL91:       \"items\": {\nL92:         \"type\": \"string\",\nL93:         \"minLength\": 12\nL94:       },\nL95:       \"minItems\": 3,\nL96:       \"maxItems\": 8\nL97:     }\nL98:   },\nL99:   \"required\": [\nL100:     \"paper\",\nL101:     \"core_question\",\nL102:     \"datasets_or_cohorts\",\nL103:     \"major_limitations\"\nL104:   ],\nL105:   \"additionalProperties\": false\nL106: }"
          }
        ],
        "usage": {
          "promptTokens": 778,
          "responseTokens": 19,
          "thinkingTokens": 9,
          "totalTokens": 806
        },
        "costUsd": 0
      },
      {
        "step": 4,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Analyzing Schema Development**\n\nI'm currently focused on the schema for quantitative findings, specifically reviewing `quantitative_findings.schema.json`. I'm checking the structure, ensuring it aligns with the data I anticipate, and considering potential edge cases for maximum robustness.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "schemas/quantitative_findings.schema.json"
            },
            "output": "L1: {\nL2:   \"$schema\": \"http://json-schema.org/draft-07/schema#\",\nL3:   \"title\": \"schemas-quantitative_findings\",\nL4:   \"type\": \"object\",\nL5:   \"properties\": {\nL6:     \"findings\": {\nL7:       \"type\": \"array\",\nL8:       \"items\": {\nL9:         \"type\": \"object\",\nL10:         \"properties\": {\nL11:           \"id\": {\nL12:             \"type\": \"string\",\nL13:             \"pattern\": \"^Q[0-9]{2}$\"\nL14:           },\nL15:           \"metric\": {\nL16:             \"type\": \"string\",\nL17:             \"minLength\": 6\nL18:           },\nL19:           \"value\": {\nL20:             \"type\": \"string\",\nL21:             \"minLength\": 1\nL22:           },\nL23:           \"comparator_or_baseline\": {\nL24:             \"type\": \"string\",\nL25:             \"minLength\": 1\nL26:           },\nL27:           \"interpretation\": {\nL28:             \"type\": \"string\",\nL29:             \"minLength\": 12\nL30:           },\nL31:           \"evidence_line_refs\": {\nL32:             \"type\": \"array\",\nL33:             \"items\": {\nL34:               \"type\": \"string\",\nL35:               \"pattern\": \"^L[1-9]\\\\d*$\"\nL36:             },\nL37:             \"minItems\": 1,\nL38:             \"maxItems\": 3\nL39:           }\nL40:         },\nL41:         \"required\": [\nL42:           \"id\",\nL43:           \"metric\",\nL44:           \"value\",\nL45:           \"comparator_or_baseline\",\nL46:           \"interpretation\",\nL47:           \"evidence_line_refs\"\nL48:         ],\nL49:         \"additionalProperties\": false\nL50:       },\nL51:       \"minItems\": 5,\nL52:       \"maxItems\": 14\nL53:     },\nL54:     \"controls_or_null_results\": {\nL55:       \"type\": \"array\",\nL56:       \"items\": {\nL57:         \"type\": \"object\",\nL58:         \"properties\": {\nL59:           \"statement\": {\nL60:             \"type\": \"string\",\nL61:             \"minLength\": 10\nL62:           },\nL63:           \"evidence_line_ref\": {\nL64:             \"$ref\": \"#/definitions/schemas-quantitative_findings/properties/findings/items/properties/evidence_line_refs/items\"\nL65:           }\nL66:         },\nL67:         \"required\": [\nL68:           \"statement\",\nL69:           \"evidence_line_ref\"\nL70:         ],\nL71:         \"additionalProperties\": false\nL72:       },\nL73:       \"minItems\": 2,\nL74:       \"maxItems\": 10\nL75:     }\nL76:   },\nL77:   \"required\": [\nL78:     \"findings\",\nL79:     \"controls_or_null_results\"\nL80:   ],\nL81:   \"additionalProperties\": false\nL82: }"
          }
        ],
        "usage": {
          "promptTokens": 1917,
          "responseTokens": 19,
          "thinkingTokens": 12,
          "totalTokens": 1948
        },
        "costUsd": 0
      },
      {
        "step": 5,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Mapping the Schema Now**\n\nI'm currently working on the next schema, focusing on `claim_audit.schema.json`. I'm meticulously mapping the structure, ensuring it aligns with the data requirements. I am considering edge cases, and aiming for optimal design.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "schemas/claim_audit.schema.json"
            },
            "output": "L1: {\nL2:   \"$schema\": \"http://json-schema.org/draft-07/schema#\",\nL3:   \"title\": \"schemas-claim_audit\",\nL4:   \"type\": \"object\",\nL5:   \"properties\": {\nL6:     \"claims\": {\nL7:       \"type\": \"array\",\nL8:       \"items\": {\nL9:         \"type\": \"object\",\nL10:         \"properties\": {\nL11:           \"claim_id\": {\nL12:             \"type\": \"string\",\nL13:             \"pattern\": \"^C[0-9]{2}$\"\nL14:           },\nL15:           \"claim\": {\nL16:             \"type\": \"string\",\nL17:             \"minLength\": 20\nL18:           },\nL19:           \"strength\": {\nL20:             \"type\": \"string\",\nL21:             \"enum\": [\nL22:               \"strong\",\nL23:               \"moderate\",\nL24:               \"tentative\"\nL25:             ]\nL26:           },\nL27:           \"evidence\": {\nL28:             \"type\": \"array\",\nL29:             \"items\": {\nL30:               \"type\": \"object\",\nL31:               \"properties\": {\nL32:                 \"quote\": {\nL33:                   \"type\": \"string\",\nL34:                   \"minLength\": 10\nL35:                 },\nL36:                 \"line_ref\": {\nL37:                   \"type\": \"string\",\nL38:                   \"pattern\": \"^L[1-9]\\\\d*$\"\nL39:                 }\nL40:               },\nL41:               \"required\": [\nL42:                 \"quote\",\nL43:                 \"line_ref\"\nL44:               ],\nL45:               \"additionalProperties\": false\nL46:             },\nL47:             \"minItems\": 2,\nL48:             \"maxItems\": 3\nL49:           },\nL50:           \"caveat\": {\nL51:             \"type\": \"string\",\nL52:             \"minLength\": 20\nL53:           }\nL54:         },\nL55:         \"required\": [\nL56:           \"claim_id\",\nL57:           \"claim\",\nL58:           \"strength\",\nL59:           \"evidence\",\nL60:           \"caveat\"\nL61:         ],\nL62:         \"additionalProperties\": false\nL63:       },\nL64:       \"minItems\": 4,\nL65:       \"maxItems\": 10\nL66:     }\nL67:   },\nL68:   \"required\": [\nL69:     \"claims\"\nL70:   ],\nL71:   \"additionalProperties\": false\nL72: }"
          }
        ],
        "usage": {
          "promptTokens": 2825,
          "responseTokens": 19,
          "thinkingTokens": 12,
          "totalTokens": 2856
        },
        "costUsd": 0
      },
      {
        "step": 6,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Mapping the Schema Structure**\n\nI'm currently working to establish the structure for the `public_summary.schema.json` file. My goal is to carefully define all the necessary fields and relationships to accurately represent the data needed. I'm focusing on clarity and efficiency, ensuring the schema is both comprehensive and easy to use.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "schemas/public_summary.schema.json"
            },
            "output": "L1: {\nL2:   \"$schema\": \"http://json-schema.org/draft-07/schema#\",\nL3:   \"title\": \"schemas-public_summary\",\nL4:   \"type\": \"object\",\nL5:   \"properties\": {\nL6:     \"headline\": {\nL7:       \"type\": \"string\",\nL8:       \"minLength\": 20,\nL9:       \"maxLength\": 120\nL10:     },\nL11:     \"plain_language_summary\": {\nL12:       \"type\": \"string\",\nL13:       \"minLength\": 180,\nL14:       \"maxLength\": 1200\nL15:     },\nL16:     \"what_is_new\": {\nL17:       \"type\": \"array\",\nL18:       \"items\": {\nL19:         \"type\": \"string\",\nL20:         \"minLength\": 20\nL21:       },\nL22:       \"minItems\": 3,\nL23:       \"maxItems\": 3\nL24:     },\nL25:     \"why_caution_is_needed\": {\nL26:       \"type\": \"array\",\nL27:       \"items\": {\nL28:         \"type\": \"string\",\nL29:         \"minLength\": 20\nL30:       },\nL31:       \"minItems\": 3,\nL32:       \"maxItems\": 5\nL33:     },\nL34:     \"glossary\": {\nL35:       \"type\": \"array\",\nL36:       \"items\": {\nL37:         \"type\": \"object\",\nL38:         \"properties\": {\nL39:           \"term\": {\nL40:             \"type\": \"string\",\nL41:             \"minLength\": 2\nL42:           },\nL43:           \"definition\": {\nL44:             \"type\": \"string\",\nL45:             \"minLength\": 20,\nL46:             \"maxLength\": 220\nL47:           }\nL48:         },\nL49:         \"required\": [\nL50:           \"term\",\nL51:           \"definition\"\nL52:         ],\nL53:         \"additionalProperties\": false\nL54:       },\nL55:       \"minItems\": 4,\nL56:       \"maxItems\": 8\nL57:     },\nL58:     \"open_questions\": {\nL59:       \"type\": \"array\",\nL60:       \"items\": {\nL61:         \"type\": \"string\",\nL62:         \"minLength\": 20\nL63:       },\nL64:       \"minItems\": 3,\nL65:       \"maxItems\": 6\nL66:     }\nL67:   },\nL68:   \"required\": [\nL69:     \"headline\",\nL70:     \"plain_language_summary\",\nL71:     \"what_is_new\",\nL72:     \"why_caution_is_needed\",\nL73:     \"glossary\",\nL74:     \"open_questions\"\nL75:   ],\nL76:   \"additionalProperties\": false\nL77: }"
          }
        ],
        "usage": {
          "promptTokens": 3577,
          "responseTokens": 19,
          "thinkingTokens": 12,
          "totalTokens": 3608
        },
        "costUsd": 0
      },
      {
        "step": 7,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Reviewing the Input**\n\nI've just finished digesting the schemas and am shifting my focus. The next logical step is to delve into the `input/report.md` file. I'll need to extract relevant information from it.",
        "toolCalls": [
          {
            "toolName": "read_file",
            "input": {
              "file_path": "input/report.md"
            },
            "output": "L1: # Structured Paper Report: Tumor Sensitization by mRNA Vaccination\nL2: \nL3: ## Citation\nL4: - Title: SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade\nL5: - Journal: Nature\nL6: - Year: 2025\nL7: - DOI: 10.1038/s41586-025-09006-8\nL8: - Source URL: https://www.nature.com/articles/s41586-025-09006-8\nL9: \nL10: ## One-Paragraph Context\nL11: Immune checkpoint inhibitors (ICIs) can produce durable responses in some cancers, but many tumors remain non-responsive due to weak antigen presentation or poor immune priming. The paper investigates whether intratumoral delivery of an mRNA vaccine can create an interferon-rich inflammatory state that improves sensitivity to anti-PD-L1 therapy.\nL12: \nL13: ## Study Design Snapshot\nL14: - Preclinical arm: multiple murine tumor models with intratumoral mRNA vaccine and anti-PD-L1 combinations.\nL15: - Translational arm: a retrospective cohort of metastatic patients receiving ICI treatment, compared by prior SARS-CoV-2 mRNA vaccination status.\nL16: - Mechanistic probes: immunopeptidomics, transcriptomics, and perturbation controls (including IFNAR1 blockade and non-mRNA particle controls).\nL17: \nL18: ## Cohorts and Scenarios\nL19: 1. Mouse efficacy cohort (combination therapy): 78 tumor-bearing mice pooled across repeat experiments.\nL20: 2. Mouse control cohort (vaccine only, ICI only, and vehicle): 84 tumor-bearing mice pooled across matched controls.\nL21: 3. Human retrospective metastatic cohort: 130 patients total.\nL22: 4. Human vaccinated subgroup: 43 patients.\nL23: 5. Human unvaccinated subgroup: 87 patients.\nL24: \nL25: ## Quantitative Findings\nL26: | Metric | Vaccine/Combination Arm | Comparator | Interpretation |\nL27: |---|---:|---:|---|\nL28: | Fraction of tumor proteins represented in immunopeptidome | 62.3% | 37.3% | Broader antigen display after intratumoral mRNA vaccination |\nL29: | Fraction of proteins represented in MHC-I peptidome | 40.6% | 20.6% | Strong expansion of MHC-I-presented landscape |\nL30: | Retrospective human survival comparison p-value | p=0.01 | N/A | Vaccinated subgroup had improved survival under ICI treatment |\nL31: | Type I interferon response score (normalized units) | 3.1 | 1.0 | Marked induction after mRNA vaccination in tumors |\nL32: | PD-L1 expression fold-change in tumor tissue | 2.4x | 1.0x | Checkpoint axis became more targetable |\nL33: | Intratumoral CD8+ T-cell density fold-change | 1.8x | 1.0x | Increased immune infiltration with combination therapy |\nL34: \nL35: ## Controls and Null/Conditional Results\nL36: - Vaccine-only treatment did not produce durable tumor control in non-immunogenic models.\nL37: - ICI-only treatment had limited activity in low-immunogenic baseline settings.\nL38: - Lipid particle controls lacking mRNA did not reproduce the sensitization effect.\nL39: - Blocking type I interferon signaling with anti-IFNAR1 eliminated the observed sensitization benefit.\nL40: \nL41: ## Mechanistic Chain Proposed by Authors\nL42: 1. Intratumoral mRNA vaccination triggers local innate sensing and type I interferon signaling.\nL43: 2. Interferon-associated antigen processing and presentation pathways increase.\nL44: 3. A broader peptide repertoire appears on MHC-I, improving tumor visibility to T cells.\nL45: 4. PD-L1 pathway activity also increases, creating a rationale for combining with checkpoint blockade.\nL46: 5. Combined intervention improves tumor control in mice and aligns with better outcomes in the retrospective human cohort.\nL47: \nL48: ## Caveats and Threats to Validity\nL49: - The human analysis is retrospective and non-randomized; residual confounding is likely.\nL50: - Vaccination timing relative to ICI initiation varied across patients.\nL51: - Tumor-type mix and treatment-history heterogeneity limit direct causal interpretation.\nL52: - Mouse model effects may not map one-to-one to all human tumors.\nL53: - Some mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings.\nL54: \nL55: ## Practical Takeaway\nL56: The study supports a biologically coherent hypothesis that intratumoral mRNA vaccination can prime tumors for stronger ICI responses, but prospective randomized studies are required before clinical protocol changes are justified."
          }
        ],
        "usage": {
          "promptTokens": 4423,
          "responseTokens": 15,
          "thinkingTokens": 23,
          "totalTokens": 4461
        },
        "costUsd": 0
      },
      {
        "step": 8,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Initiating Data Compilation**\n\nI'm now diving into the specifics. I'm taking the report's information and using it to populate each JSON file. First up, the `output/study_overview.json` file. The title for `paper.title` is set, and I'll begin on the next key.\n\n\n**Mapping the JSON Files**\n\nI am now focusing on populating the `output/study_overview.json` file. I've successfully extracted the title, DOI, publication year, and the domain which is \"oncology-immunology\". Next, I'll extract study type, core question, and datasets.\n\n\n**Populating JSON Fields**\n\nI'm presently building the `output/study_overview.json` using the provided report data. I'm now focused on the remaining fields. I've successfully extracted the `study_type`, `core_question`, and `datasets_or_cohorts` for this file and will shortly move on to major limitations.\n\n\n**Completing File Extraction**\n\nI'm making progress in gathering the information for the JSON files. Specifically, I've compiled the `output/study_overview.json` with the major limitations. Now, I'm shifting focus to extract the necessary information from the provided report and to begin populating the `output/quantitative_findings.json` and `output/claim_audit.json` files.\n\n\n**Processing Report Details**\n\nI have finished the initial extraction and have moved onto populating the other JSON files. I am extracting and formatting data for `output/quantitative_findings.json` and `output/claim_audit.json`. I have begun extracting data from the report to create the respective fields.\n\n\n**Completing JSON File Generation**\n\nI've completed extracting the data, specifically focusing on generating the JSON files, drawing directly from the provided report. I've now generated the  `output/quantitative_findings.json`, and `output/claim_audit.json` files. My next step will be working on the `output/public_summary.json` file.\n\n\n**Constructing the Final Summary**\n\nI am now focusing on the final step: creating the `output/public_summary.json` file. I'm extracting the necessary information to create the headline, the plain language summary, and the \"what is new,\" \"why caution is needed,\" and \"glossary\" sections. This will synthesize the report's key findings into a concise overview.\n\n\n**Extracting the Data**\n\nI have completed the data extraction for the study. I've now gathered all the necessary details to populate the `output/study_overview.json`, `output/quantitative_findings.json`, `output/claim_audit.json`, and  `output/public_summary.json` files. My focus is now on constructing the `output/public_summary.json` file.\n\n\n**Summarizing Final Details**\n\nI'm presently structuring the `output/public_summary.json` file, focusing on the `headline`, `plain_language_summary`, and other key sections. I'm extracting and summarizing the critical data points from the report, aiming for conciseness while accurately conveying the core findings, and ensuring compliance with the output length constraints. My attention is now on refining the text.\n\n\n**Finalizing Public Summary Details**\n\nI am in the final stages, polishing the `output/public_summary.json`. I have reviewed the `headline` and `plain_language_summary` for clarity and length compliance. The `glossary` entries are all within character limits, and I am double-checking the accuracy of all cross-references and ensuring no key information is omitted. I am now preparing the final output to meet all requirements.\n\n\n**Polishing the Final Output**\n\nMy focus remains on the final `output/public_summary.json` file. I have meticulously refined the  `headline`, `plain_language_summary`, and glossary definitions to meet all constraints. The data extraction is complete, and the information is accurately reflected in the `output/study_overview.json`, `output/quantitative_findings.json`, and `output/claim_audit.json` files.\n\n\n**Generating Final JSON Structures**\n\nI'm now fully immersed in the construction phase, specifically generating the required JSON files using the compiled data. I'm taking the report's information and integrating it into each JSON file. I'm focusing on ensuring all the generated files are correct and comply with the pre-defined constraints before finalizing the process.",
        "toolCalls": [
          {
            "toolName": "write_file",
            "input": {
              "file_path": "output/study_overview.json",
              "content": "{\n  \"paper\": {\n    \"title\": \"SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade\",\n    \"doi\": \"10.1038/s41586-025-09006-8\",\n    \"publication_year\": 2025,\n    \"domain\": \"oncology-immunology\",\n    \"study_type\": \"preclinical+retrospective\"\n  },\n  \"core_question\": \"Can intratumoral delivery of an mRNA vaccine create an interferon-rich inflammatory state that improves sensitivity to anti-PD-L1 therapy?\",\n  \"datasets_or_cohorts\": [\n    {\n      \"id\": \"mouse-efficacy\",\n      \"label\": \"Mouse efficacy combination cohort\",\n      \"sample_size_or_observations\": \"78 mice\",\n      \"description\": \"Multiple murine tumor models with intratumoral mRNA vaccine and anti-PD-L1 combinations.\"\n    },\n    {\n      \"id\": \"mouse-controls\",\n      \"label\": \"Mouse control cohort\",\n      \"sample_size_or_observations\": \"84 mice\",\n      \"description\": \"Matched controls including vaccine-only, ICI-only, and vehicle treatments across repeat experiments.\"\n    },\n    {\n      \"id\": \"human-retrospective\",\n      \"label\": \"Human retrospective cohort\",\n      \"sample_size_or_observations\": \"130 patients\",\n      \"description\": \"Metastatic patients receiving ICI treatment, compared by prior SARS-CoV-2 mRNA vaccination status.\"\n    }\n  ],\n  \"major_limitations\": [\n    \"The human analysis is retrospective and non-randomized; residual confounding is likely.\",\n    \"Vaccination timing relative to ICI initiation varied across patients.\",\n    \"Tumor-type mix and treatment-history heterogeneity limit direct causal interpretation.\",\n    \"Mouse model effects may not map one-to-one to all human tumors.\"\n  ]\n}"
            },
            "output": "Successfully wrote file: output/study_overview.json"
          }
        ],
        "usage": {
          "promptTokens": 5590,
          "cachedTokens": 3349,
          "responseTokens": 459,
          "thinkingTokens": 3415,
          "totalTokens": 9464
        },
        "costUsd": 0
      },
      {
        "step": 9,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Assessing Quantitative Data**\n\nI'm currently reviewing the quantitative findings. I've begun to cross-reference the data points within `output/quantitative_findings.json` to identify trends. My focus is on discerning statistically significant relationships between variables. I'm also planning to create visualizations to illustrate the key patterns.",
        "toolCalls": [
          {
            "toolName": "write_file",
            "input": {
              "file_path": "output/quantitative_findings.json",
              "content": "{\n  \"findings\": [\n    {\n      \"id\": \"Q01\",\n      \"metric\": \"Fraction of tumor proteins represented in immunopeptidome\",\n      \"value\": \"62.3%\",\n      \"comparator_or_baseline\": \"37.3%\",\n      \"interpretation\": \"Broader antigen display after intratumoral mRNA vaccination\",\n      \"evidence_line_refs\": [\n        \"L28\"\n      ]\n    },\n    {\n      \"id\": \"Q02\",\n      \"metric\": \"Fraction of proteins represented in MHC-I peptidome\",\n      \"value\": \"40.6%\",\n      \"comparator_or_baseline\": \"20.6%\",\n      \"interpretation\": \"Strong expansion of MHC-I-presented landscape\",\n      \"evidence_line_refs\": [\n        \"L29\"\n      ]\n    },\n    {\n      \"id\": \"Q03\",\n      \"metric\": \"Retrospective human survival comparison p-value\",\n      \"value\": \"p=0.01\",\n      \"comparator_or_baseline\": \"N/A\",\n      \"interpretation\": \"Vaccinated subgroup had improved survival under ICI treatment\",\n      \"evidence_line_refs\": [\n        \"L30\"\n      ]\n    },\n    {\n      \"id\": \"Q04\",\n      \"metric\": \"Type I interferon response score (normalized units)\",\n      \"value\": \"3.1\",\n      \"comparator_or_baseline\": \"1.0\",\n      \"interpretation\": \"Marked induction after mRNA vaccination in tumors\",\n      \"evidence_line_refs\": [\n        \"L31\"\n      ]\n    },\n    {\n      \"id\": \"Q05\",\n      \"metric\": \"PD-L1 expression fold-change in tumor tissue\",\n      \"value\": \"2.4x\",\n      \"comparator_or_baseline\": \"1.0x\",\n      \"interpretation\": \"Checkpoint axis became more targetable\",\n      \"evidence_line_refs\": [\n        \"L32\"\n      ]\n    },\n    {\n      \"id\": \"Q06\",\n      \"metric\": \"Intratumoral CD8+ T-cell density fold-change\",\n      \"value\": \"1.8x\",\n      \"comparator_or_baseline\": \"1.0x\",\n      \"interpretation\": \"Increased immune infiltration with combination therapy\",\n      \"evidence_line_refs\": [\n        \"L33\"\n      ]\n    }\n  ],\n  \"controls_or_null_results\": [\n    {\n      \"statement\": \"Vaccine-only treatment did not produce durable tumor control in non-immunogenic models.\",\n      \"evidence_line_ref\": \"L36\"\n    },\n    {\n      \"statement\": \"ICI-only treatment had limited activity in low-immunogenic baseline settings.\",\n      \"evidence_line_ref\": \"L37\"\n    },\n    {\n      \"statement\": \"Lipid particle controls lacking mRNA did not reproduce the sensitization effect.\",\n      \"evidence_line_ref\": \"L38\"\n    },\n    {\n      \"statement\": \"Blocking type I interferon signaling with anti-IFNAR1 eliminated the observed sensitization benefit.\",\n      \"evidence_line_ref\": \"L39\"\n    }\n  ]\n}"
            },
            "output": "Successfully wrote file: output/quantitative_findings.json"
          }
        ],
        "usage": {
          "promptTokens": 6060,
          "responseTokens": 776,
          "thinkingTokens": 13,
          "totalTokens": 6849
        },
        "costUsd": 0
      },
      {
        "step": 10,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Reflecting on Claim Audits**\n\nI'm currently focusing on the `claim_audit.json` file. My latest thinking revolves around the structure of this data and how it might be best utilized. I've begun to model possible scenarios for analysis, including identifying discrepancies and potential fraud, and now I'm thinking about the most efficient querying methods.",
        "toolCalls": [
          {
            "toolName": "write_file",
            "input": {
              "file_path": "output/claim_audit.json",
              "content": "{\n  \"claims\": [\n    {\n      \"claim_id\": \"C01\",\n      \"claim\": \"Intratumoral mRNA vaccination triggers local innate sensing and type I interferon signaling.\",\n      \"strength\": \"strong\",\n      \"evidence\": [\n        {\n          \"quote\": \"Intratumoral mRNA vaccination triggers local innate sensing and type I interferon signaling.\",\n          \"line_ref\": \"L42\"\n        },\n        {\n          \"quote\": \"Type I interferon response score (normalized units) | 3.1 | 1.0\",\n          \"line_ref\": \"L31\"\n        }\n      ],\n      \"caveat\": \"Some mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings.\"\n    },\n    {\n      \"claim_id\": \"C02\",\n      \"claim\": \"mRNA vaccination increases the breadth of the peptide repertoire appearing on MHC-I.\",\n      \"strength\": \"strong\",\n      \"evidence\": [\n        {\n          \"quote\": \"Fraction of proteins represented in MHC-I peptidome | 40.6% | 20.6%\",\n          \"line_ref\": \"L29\"\n        },\n        {\n          \"quote\": \"A broader peptide repertoire appears on MHC-I, improving tumor visibility to T cells.\",\n          \"line_ref\": \"L44\"\n        }\n      ],\n      \"caveat\": \"Some mechanistic readouts were strongest in specific model systems rather than uniformly across all tested settings.\"\n    },\n    {\n      \"claim_id\": \"C03\",\n      \"claim\": \"Intratumoral mRNA vaccine sensitizes tumors to anti-PD-L1 therapy.\",\n      \"strength\": \"moderate\",\n      \"evidence\": [\n        {\n          \"quote\": \"The study supports a biologically coherent hypothesis that intratumoral mRNA vaccination can prime tumors for stronger ICI responses\",\n          \"line_ref\": \"L56\"\n        },\n        {\n          \"quote\": \"Combined intervention improves tumor control in mice and aligns with better outcomes in the retrospective human cohort.\",\n          \"line_ref\": \"L46\"\n        }\n      ],\n      \"caveat\": \"The human analysis is retrospective and non-randomized; residual confounding is likely.\"\n    },\n    {\n      \"claim_id\": \"C04\",\n      \"claim\": \"SARS-CoV-2 mRNA vaccination status is associated with improved survival in human patients receiving ICI.\",\n      \"strength\": \"tentative\",\n      \"evidence\": [\n        {\n          \"quote\": \"Retrospective human survival comparison p-value | p=0.01 | N/A | Vaccinated subgroup had improved survival under ICI treatment\",\n          \"line_ref\": \"L30\"\n        },\n        {\n          \"quote\": \"the retrospective human cohort... align with better outcomes\",\n          \"line_ref\": \"L46\"\n        }\n      ],\n      \"caveat\": \"Tumor-type mix and treatment-history heterogeneity limit direct causal interpretation.\"\n    }\n  ]\n}"
            },
            "output": "Successfully wrote file: output/claim_audit.json"
          }
        ],
        "usage": {
          "promptTokens": 6847,
          "responseTokens": 706,
          "thinkingTokens": 13,
          "totalTokens": 7566
        },
        "costUsd": 0
      },
      {
        "step": 11,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Analyzing The Output File**\n\nI'm currently reviewing `output/public_summary.json`. I'm focusing on the data structure and content within, specifically how information is organized and presented. Initial observations indicate a JSON format, which I'm now cross-referencing with other outputs to check for consistency and potential errors.",
        "toolCalls": [
          {
            "toolName": "write_file",
            "input": {
              "file_path": "output/public_summary.json",
              "content": "{\n  \"headline\": \"mRNA vaccination helps tumors respond better to immunotherapy treatments\",\n  \"plain_language_summary\": \"This study explores how injecting mRNA vaccines directly into tumors can make them more sensitive to immune checkpoint inhibitors (ICIs), a common type of immunotherapy. The researchers found that mRNA vaccines trigger a strong interferon response, which in turn increases the number of different tumor proteins displayed to the immune system. This broader display makes the tumor more 'visible' to T cells. In mouse models, the combination of mRNA vaccination and ICI treatment significantly improved tumor control. Furthermore, a retrospective study of 130 human patients suggested that those who had received a SARS-CoV-2 mRNA vaccine before starting immunotherapy had better survival outcomes, although more rigorous clinical trials are needed to confirm this.\",\n  \"what_is_new\": [\n    \"Intratumoral mRNA delivery broadens the diversity of tumor antigens presented on MHC-I.\",\n    \"Prior SARS-CoV-2 mRNA vaccination is associated with improved outcomes in human ICI patients.\",\n    \"Blocking type I interferon signaling completely eliminates the sensitization effect of the vaccine.\"\n  ],\n  \"why_caution_is_needed\": [\n    \"The human data is retrospective, meaning it looks back at past events and cannot prove cause and effect.\",\n    \"Patient heterogeneity in tumor types and treatment histories might influence the observed outcomes.\",\n    \"Results seen in mouse models do not always translate perfectly to human patients.\"\n  ],\n  \"glossary\": [\n    {\n      \"term\": \"Immune Checkpoint Inhibitor (ICI)\",\n      \"definition\": \"A type of drug that helps the immune system recognize and attack cancer cells.\"\n    },\n    {\n      \"term\": \"mRNA Vaccine\",\n      \"definition\": \"A vaccine that uses a piece of genetic material to instruct cells to produce a specific protein.\"\n    },\n    {\n      \"term\": \"Immunopeptidome\",\n      \"definition\": \"The set of all peptide fragments presented on the surface of cells for recognition by the immune system.\"\n    },\n    {\n      \"term\": \"MHC-I\",\n      \"definition\": \"A molecule on the surface of most cells that displays protein fragments to CD8+ T cells.\"\n    }\n  ],\n  \"open_questions\": [\n    \"Will these findings hold true in a prospective, randomized clinical trial?\",\n    \"Does the timing of vaccination relative to starting immunotherapy significantly impact the results?\",\n    \"Are these effects consistent across all types of solid tumors?\"\n  ]\n}"
            },
            "output": "Successfully wrote file: output/public_summary.json"
          }
        ],
        "usage": {
          "promptTokens": 7564,
          "cachedTokens": 2508,
          "responseTokens": 558,
          "thinkingTokens": 13,
          "totalTokens": 8135
        },
        "costUsd": 0
      },
      {
        "step": 12,
        "modelVersion": "gemini-3-flash-preview",
        "thoughts": "**Confirming File Completions**\n\nI've completed the initial draft of the output files. I'm now cross-referencing to ensure all components are present and compliant with the schema specifications. Initial validation checks are complete, and I'll proceed with more in-depth reviews.\n\n\n**Double-Checking Data Integrity**\n\nI've reviewed all generated files to confirm they match their respective schemas. I paid specific attention to the `quantitative_findings.json`, and confirmed the absence of calculation outputs. I thus confirmed the appropriate use of line references for the values from the report. I also re-examined `claim_audit.json` to verify the accuracy of the evidence quotes. All quotes match precisely.\n\n\n**Revising Claim Evidence**\n\nI've just finished reviewing the output files, confirming each one's schema compliance. During a second pass over `quantitative_findings.json`, I verified the correct use of line references for the values, as there are no calculation outputs. I also revisited `claim_audit.json` and corrected one of the evidence quotes to be exact. I'm now making a final review of `public_summary.json` before finishing up.\n\n\n**Confirming Final Details**\n\nI've validated all files against their schemas, and verified data integrity. I've corrected an evidence quote in `claim_audit.json` to be exact and confirmed the correct use of line references in `quantitative_findings.json`. I confirmed the length requirements of the summary files. A final review is now in progress.\n\n\n**Performing Final Validation**\n\nI've re-examined the line references in `quantitative_findings.json`, and they are correct. Furthermore, I've confirmed that I'm using exact report snippets as evidence quotes, even if they are substrings of the lines. I am now doing a final check of all files to ensure complete accuracy.\n\n\n**Verifying Exact Quotes**\n\nI've re-examined the output files, confirming their schema compliance. The line references in `quantitative_findings.json` are correct as they only reference the lines with values from the report. I also re-checked `claim_audit.json` to make sure all the quotes are exact matches to the report snippets, even if they are substrings. I'll perform a final validation.\n\n\n**Re-evaluating Quote Precision**\n\nI've re-examined the output files, confirming their schema compliance. I've corrected a previous error and updated `claim_audit.json` with the more precise quote: \"aligns with better outcomes in the retrospective human cohort\" from line 46. I'm now verifying the exactness of all quotes in `claim_audit.json`, checking each against the source report, ensuring the \"exact report snippet\" requirement is met. I'm still finalizing the output.\n\n\n**Refining Evidence Quotes**\n\nI've re-examined the output files, confirming their schema compliance. I corrected a previous error and updated `claim_audit.json` with the more precise quote: \"aligns with better outcomes in the retrospective human cohort\" from line 46. I've also verified that the quotes in `claim_audit.json` are exact matches to report snippets. Now, I'm ready to finalize.",
        "toolCalls": [
          {
            "toolName": "replace",
            "input": {
              "file_path": "output/claim_audit.json",
              "instruction": "Update C04 second evidence quote to be an exact snippet.",
              "old_string": "\"quote\": \"the retrospective human cohort... align with better outcomes\",",
              "new_string": "\"quote\": \"aligns with better outcomes in the retrospective human cohort.\",",
              "expected_replacements": 1
            },
            "output": "Successfully replaced 1 occurrence(s) in output/claim_audit.json."
          }
        ],
        "usage": {
          "promptTokens": 8133,
          "cachedTokens": 5137,
          "responseTokens": 69,
          "thinkingTokens": 1920,
          "totalTokens": 10122
        },
        "costUsd": 0
      },
      {
        "step": 13,
        "modelVersion": "gemini-3-flash-preview",
        "text": "- [x] `output/study_overview.json`\n- [x] `output/quantitative_findings.json`\n- [x] `output/claim_audit.json`\n- [x] `output/public_summary.json`",
        "thoughts": "**Checking the Files**\n\nI've just finished the final review of the files. All essential elements in the `output/study_overview.json` file, like titles, DOIs, publication years, domains, and study types are present and seem to be in order. The core questions are also there. I'm satisfied.\n\n\n**Validating All Data**\n\nI'm now satisfied with the file structures. I've re-examined the contents to ensure data integrity. Specifically, I confirmed that the expected fields are present within `study_overview.json`, `quantitative_findings.json`, `claim_audit.json`, and `public_summary.json`. Further, I spot-checked the `plain_language_summary` in `public_summary.json`, and it's within the required length constraints. I'm now proceeding to a final validation round to verify data accuracy across all fields. I'm also ensuring the \"domain\" field is correctly populated.\n\n\n**Concluding the Review**\n\nI've completed my final data checks. All files, including `study_overview.json`, `quantitative_findings.json`, `claim_audit.json`, and `public_summary.json`, have been meticulously reviewed. I've confirmed data types, lengths, and formatting. The evidence line references in `quantitative_findings.json` are correct. I'm now certain the output meets all the requirements.\n\n\n**Confirming Final Checks**\n\nI've just run a final, thorough review. I validated all file content, including all JSON elements, confirming the presence, format, and accuracy of each data point across all the files. I've double-checked the evidence line references, and all quotes, and can confirm that all the output files meet all of the requirements. The process is now complete.",
        "toolCalls": [],
        "usage": {
          "promptTokens": 8217,
          "cachedTokens": 6723,
          "responseTokens": 55,
          "thinkingTokens": 986,
          "totalTokens": 9258
        },
        "costUsd": 0
      }
    ],
    "totalCostUsd": 0
  }
}
